Sentient Synthetics is an AI-based, digital pathology company leveraging machine learning to create synthetic pathology datasets for the purpose of overcoming existing data limitations in the field of computational pathology.

These synthetic datasets are validated, affordable, thoroughly labeled, and free from privacy concerns.

They aim to enable faster and more accurate training and validation for highly accurate AI algorithms by medical research centers, digital health, pharmaceutical companies, and diagnostics, for all cancer tissue types, including the rarer forms.Sentient is a Technion spin-off company.